|
⚲
|
| Keyboard |
| Bhanji Muna
✚
|
|
|---|---|
| CIK # | 0001846905 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001846905] | |
| 4 | [0001846905] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ardelyx Inc | |
| Bhanji Muna | |
| Veracyte Inc | |
| Intellia Therapeutics Inc | |
| Cytokinetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Veracyte Inc VCYT
Common Stock
|
2025-06-18 | Grant | 9,321 | $0.00 | |
|
Ardelyx Inc ARDX
Common Stock
|
2025-06-18 | Grant | 41,551 | $0.00 | |
|
Ardelyx Inc ARDX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 54,059 | $0.00 | |
|
Veracyte Inc VCYT
Common Stock
|
2025-06-13 | Sell | 4,589 | $26.67 | 122,389 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-06-11 | Grant | 8,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 11,450 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2025-05-15 | Sell | 1,454 | $29.73 | 43,227 |
|
Cytokinetics Inc CYTK
Common Stock
|
2025-05-14 | Grant | 7,333 | $0.00 | |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2025-05-14 | Grant | 10,880 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-04-29 | Sell | 265 | $8.50 | 2,252 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-29 | Sell | 265 | $9.97 | 2,642 |
|
Ardelyx Inc ARDX
Stock Option (Right to Buy) · derivative
|
2024-06-14 | Grant | 40,243 | $0.00 | |
|
Veracyte Inc VCYT
Common Stock
|
2024-06-13 | Grant | 11,473 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-06-12 | Grant | 7,737 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2024-06-12 | Grant | 11,515 | $0.00 | |
|
Veracyte Inc VCYT
Common Stock
|
2024-06-10 | Sell | 3,870 | $20.32 | 78,638 |
|
Cytokinetics Inc CYTK
Common Stock
|
2024-06-10 | Sell | 2,000 | $52.07 | 104,140 |
|
Veracyte Inc VCYT
Common Stock
|
2024-05-28 | Sell | 1,539 | $21.00 | 32,319 |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2024-05-15 | Grant | 3,636 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2024-05-15 | Grant | 5,600 | $0.00 | |
| showing 20 of 51 most recent transactions | |||||